Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors

被引：12

作者：

Firooznia, F ^{[1
]}

Gude, C ^{[1
]}

Chan, K ^{[1
]}

Fink, CA ^{[1
]}

Qiao, Y ^{[1
]}

Satoh, Y ^{[1
]}

Marcopoulos, N ^{[1
]}

Savage, P ^{[1
]}

Beil, ME ^{[1
]}

Bruseo, CW ^{[1
]}

Trapani, AJ ^{[1
]}

Jeng, AY ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Summit, NJ 07901 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 03期

关键词：

D O I：

10.1016/S0960-894X(00)00657-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Through directed screening of metalloprotease inhibitors. CGS 30084 (1) has been identified as a potent endothelin-converting enzyme-1 (ECE-1) inhibitor in vitro (IC50 = 77 nM). Herein we report the synthesis and biological activities of analogues derived from this lead. based on modifications of the biphenyl moiety. Compound 10. the thioacetate methyl ester prodrug derivative of compound 6m. was found to he an orally active and potent inhibitor of ECE-1 activity in rats. (C) 2001 Elsevier science Ltd. All rights reserved.

引用

页码：375 / 378

页数：4

共 50 条

[41] Gene expression of endothelin-1, endothelin-converting enzyme-1, and endothelin receptors in human epididymis
Peri, A
Fantoni, G
Granchi, S
Vannelli, GB
Barni, T
Amerini, S
Pupilli, C
Barbagli, G
Forti, G
Serio, M
Maggi, M
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11): : 3797 - 3806
[42] Coexpression of endothelin-converting enzyme-1 and endothelin-1 in early stages of human atherosclerosis
Ihling, C
Szombathy, T
Schaefer, HE
Brockhaus, M
Loeffler, BM
La Roche, H
CIRCULATION, 1999, 100 (18) : 474 - 474
[43] Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin
Hoang, MV
Turner, AJ
BIOCHEMICAL JOURNAL, 1997, 327 : 23 - 26
[44] Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis
Ihling, C
Szombathy, T
Bohrmann, B
Brockhaus, M
Schaefer, HE
Loeffler, BM
CIRCULATION, 2001, 104 (08) : 864 - 869
[45] Native LDL upregulates endothelin-converting enzyme-1 in human endothelial cells
Niemann, B
Rohrbach, S
Catar, R
Muller, G
Barton, M
Morawietz, H
JOURNAL OF VASCULAR RESEARCH, 2004, 41 (05) : 458 - 458
[46] Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease
Muller, L
Barret, A
Etienne, E
Meidan, R
Valdenaire, O
Corvol, P
Tougard, C
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) : 545 - 555
[47] Endothelin-converting enzyme-1 expression in acute and chronic liver injury in fibrogenesis
Cho, Tae-Jun
Kim, Hyo-Jung
Cho, Jaejin
ANIMAL CELLS AND SYSTEMS, 2019, 23 (03) : 170 - 175
[48] Human endothelin-converting enzyme-1β mRNA expression is regulated by an alternative promoter
Funke-Kaiser, H
Orzechowski, HD
Richter, A
Paul, M
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S7 - S9
[49] Expression and localization of endothelin-converting enzyme-1 isoforms in human endothelial cells
Hunter, Alison R.
Turner, Anthony J.
EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (06) : 718 - 722
[50] The influence of dietary salt intake on the expression of endothelin-converting enzyme-1 in the kidney
Fatel, I
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (08): : 594 - 594

← 1 2 3 4 5 →